Toggle navigation
Home
Search
Services
Blog
Contact
About
Drug Design for Treatment of Inflammatory Bowel Disease
Briskin, Michael J.
Leukosite, Inc., Cambridge, MA, United States
Search 4 grants from Michael Briskin
Search grants from Leukosite, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mimicking the Architecture and Modulus of Native Brain Tissue onto Neural Implants to Improve Biocompatibility
Injectable Hydrogels to Protect Transplanted Cells from Hypoxia
Emory-Georgia TB Research Training Program
Pharmacokinetic Analysis Resource Center
Biomedical Computing Software Services
Recently added grants:
Function and RNA-mediated regulation of SCMH1 in Polycomb repression
Characterizing the (epi)genetics of oxytocin response in clinical and animal models
Role of Radial Glial Tiling in the Formation and Malformation of the Cerebral Cortex
Effects of Hospital-Community-Public Health Integration on Racial and Ethnic Disparities in Mental Health
RNA regulation of intrinsically-determined neuronal properties
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44DK049883-02
Application #
2016997
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (01))
Project Start
1995-06-15
Project End
1998-09-29
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Leukosite, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Related projects
NIH 1997
R44 DK
Drug Design for Treatment of Inflammatory Bowel Disease
Briskin, Michael J. / Leukosite, Inc.
NIH 1996
R44 DK
Drug Design for Treatment of Inflammatory Bowel Disease
Briskin, Michael J. / Leukosite, Inc.
Comments
Be the first to comment on Michael Briskin's grant